| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6818436 | Psychoneuroendocrinology | 2015 | 9 Pages |
Abstract
Taken together, extant data indicate that VEGF shows promise as a biomarker for MDD, and supports that this mediator may be involved in neuroplasticity mechanisms underlying the pathophysiology of MDD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
André F. Carvalho, Cristiano A. Köhler, Roger S. McIntyre, Christian Knöchel, André R. Brunoni, Michael E. Thase, João Quevedo, Brisa S. Fernandes, Michael Berk,